Metraipolis › archive › dc_bb5994b66bf6

Jaranol: a compound with therapeutic activity against pathological cardiac remodelling via multi-target inhibition of the Snai3/TLR2 and NF-κB signaling… — Europe PMC PMID:41552821

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41552821
DOI
10.3389/fphar.2025.1723889
License (as archived)
solo-consultazione
Archived
2026-11-07T03:08:33.665Z
SHA-256 of the archived text
dbc5867c4667217c63a890c3b221adc0bf77e8afcd7b8df7ebf74cc78c1ef479
Stable URL of this page
https://metraipolis.com/documento/dc_bb5994b66bf6

How to cite

Jaranol: a compound with therapeutic activity against pathological cardiac remodelling via multi-target inhibition of the Snai3/TLR2 and NF-κB signaling… — Europe PMC PMID:41552821 — Europe PMC (en), https://europepmc.org/article/MED/41552821 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb5994b66bf6 (Metraipolis archive dc_bb5994b66bf6, sha256 dbc5867c4667217c63a890c3b221adc0bf77e8afcd7b8df7ebf74cc78c1ef479)
BibTeX
@misc{dcbb5994b66bf6,
  title = {Jaranol: a compound with therapeutic activity against pathological cardiac remodelling via multi-target inhibition of the Snai3/TLR2 and NF-κB signaling… — Europe PMC PMID:41552821},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41552821},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb5994b66bf6; sha256 dbc5867c4667217c63a890c3b221adc0bf77e8afcd7b8df7ebf74cc78c1ef479},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41552821. Agents can read the archived copy with the MCP tool read_document.